Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Region Skane | OTHER |
| Lund University | OTHER |
Not provided
Not provided
Not provided
Not provided
The study aims to map sleep disorders and their impact on the ability to engage in an active daily life among people who have had a stroke, with particular focus on how sleep apnea can be identified.
The study has the following objectives:
There is currently a lack of understanding regarding how common sleep disorders are after stroke and how extensive their impact is on physical and psychological conditions. This project will investigate how common sleep disorders are in connection with stroke and how they affect patients with stroke physically and psychologically, as well as their level of activity in everyday life.
The project will also examine how healthcare services could identify who should undergo an assessment for sleep apnea. Today, there are commercial health technology products that alert users to potential breathing problems during the night, but it is unclear whether the information a patient presents to their doctor, based on these commercial health technology products, should be included in the clinical assessment of sleep apnea risk.
The project will consecutively invite individuals with stroke from Skåne and Blekinge, Sweden. Three months after their stroke, participants will complete questionnaires, undergo actigraphy and wear a commercial health technology product in the form of a smartwatch for one week, as well as complete an overnight respiratory recording. Based on this, it will be possible to determine how many participants have a sleep disorder and how it has affected them, as well as which factors make it likely that an individual has sleep apnea.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with ischemic stroke | Patients with first-time ischemic stroke in Skåne and Blekinge, Sweden. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of sleep apnea | Percent of participants with sleep apnea as assessed by Home Sleep Apnea Testing. | Three months post-stroke. |
| Occurrence of insomnia | Percent of participants with insomnia. | Three months post-stroke. |
| MoCA | MoCA (Montreal Cognitive Assessment) is a cognitive screening tool scored 0-30, where higher scores indicate better cognitive function; a score of 26 or above is considered normal, with an optional +1 point for individuals with ≤12 years of education. | Twelve months post-stroke. |
| MoCA | MoCA (Montreal Cognitive Assessment) is a cognitive screening tool scored 0-30, where higher scores indicate better cognitive function; a score of 26 or above is considered normal, with an optional +1 point for individuals with ≤12 years of education. | Three months post-stroke. |
| Occurrence of excessive daytime sleepiness | Percent of participants with excessive daytime sleepiness. | Three months post-stroke. |
| Physical movement behavior | Amount of time spent in different postures and activities during 24 hours. | One week of continuous accelerometer monitoring three months post-stroke. |
| Physical movement behavior | Amount of time spent in different postures and activities during 24 hours. |
| Measure | Description | Time Frame |
|---|---|---|
| Hba1c | HbA1c (Hemoglobin A1c) mmol/mol. Represents the average amount of blood sugar attached to hemoglobin over the past two to three months | Baseline. |
| Cholesterol | Serum cholesterol in mmol/L |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with stroke residing in the local referral area of Skåne University Hospital (SUS) or in the local referral area of the Department of Medicine at Blekinge Hospital Karlskrona.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Malin E. a. K. Gustafsson, M.D., Ph.D. | Contact | 0046451-29 60 00 | malin_e.gustafsson@med.lu.se |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Skånes Universitetssjukhus, SUS | Recruiting | Lund | Skåne County | Sweden |
De-identified individual participant data underlying the results reported in the published article. No directly identifiable information will be shared, and all data will be processed in accordance with the EU General Data Protection Regulation (GDPR).
Beginning after publication of the primary results and continuing for 5 years thereafter.
Qualified researchers affiliated with academic, clinical, or research institutions may request de-identified individual participant data underlying the results reported in the published article.
Researchers may submit a reasonable request to the Principal Investigator, including a description of the proposed analysis and data protection measures. Data access will be granted upon approval of the request and completion of a data-sharing agreement.
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D012891 | Sleep Apnea Syndromes |
| D020181 | Sleep Apnea, Obstructive |
| D007319 | Sleep Initiation and Maintenance Disorders |
| D006970 | Disorders of Excessive Somnolence |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| One week of continuous accelerometer monitoring twelve months post-stroke. |
| HADS | HADS (Hospital Anxiety and Depression Scale) includes two subscales (anxiety and depression) scored 0-21 each. 0 indicates no symptoms, and 21 indicates the most severe symptoms. | Three months post-stroke. |
| HADS | HADS (Hospital Anxiety and Depression Scale) includes two subscales (anxiety and depression) scored 0-21 each. 0 indicates no symptoms, and 21 indicates the most severe symptoms. | Twelve months post-stroke. |
| FAS | FAS (Fatigue Assessment Scale) is scored 10-50. 10 indicates no fatigue, and 50 indicates the most severe fatigue. | Three months post-stroke. |
| FAS | FAS (Fatigue Assessment Scale) is scored 10-50. 10 indicates no fatigue, and 50 indicates the most severe fatigue. | Twelve months post-stroke. |
| EQ-5D | EQ-5D produces an index score ranging from <0 to 1. 1 indicates full health, and lower values indicate worse health (with values below 0 representing health states considered worse than death). | Three months post-stroke. |
| EQ-5D | EQ-5D produces an index score ranging from <0 to 1. 1 indicates full health, and lower values indicate worse health (with values below 0 representing health states considered worse than death). | Twelve months post-stroke. |
| Level of breathing difficulties | Patient-reported breathing difficulties based on information they obtained from their commercial digital health smartwatch. | Three months post-stroke. |
| Baseline. |
| Creatinine | Serum creatinine in µmol/L. | Basline. |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001049 | Apnea |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D020919 | Sleep Disorders, Intrinsic |
| D020920 | Dyssomnias |
| D012893 | Sleep Wake Disorders |
| D001523 | Mental Disorders |